Information Collection: NRC Request for Information Concerning Patient Release Practices, 11471-11472 [2015-04318]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices
Targeting, Coordinating, and Reporting
Needed to Enhance Program Effectives.
One of the findings encouraged the two
agencies ‘‘to determine the extent to
which veterans’ employment outcomes
result from program participation. . .’’
As a result of the GAO
recommendations, a Joint Work Group
was directed to establish and
standardize processes to ensure disabled
veterans participating in the Chapter 31
program achieve the ultimate goal of
successful career transition and suitable
employment after the provision of Labor
Market Information and employment
services from the Jobs for Veterans State
Grant recipients. The Joint Work Group
refined processes and strengthened the
team approach to serving these disabled
veterans.
The Vocational Rehabilitation &
Employment (Chapter 31) Tracking
Report (VETS 201) is designed to
respond to the GAO finding by
compiling information on disabled
veterans jointly served by the VA, VETS
and Jobs for Veterans State Grant
recipients. All partners agree to share
information exclusively to facilitate job
development and placement services for
participating veterans. The information
is collected only with documented
consent from veterans in accordance
with the Privacy Act of 1974 and other
applicable regulations and each agency
will provide practical and appropriate
safeguards to protect Personally
Identifiable Information in accordance
with applicable regulations and laws,
including the Americans with
Disabilities Act of 1990, the
Rehabilitation Act of 1973 and
reauthorizations, and title VII of the
Civil Rights Act of 1964.
The information is collected by the
Jobs for Veterans State grant recipient
and submitted to the state Director for
Veterans’ Employment and Training
(DVET) once per Federal fiscal quarter.
The results are shared between VETS
and VA VR&E.
Estimated Annual Burden: VETS 201:
456 Hours.
Estimated Average Burden Per
Respondent: VETS 201 (Proposed): 2
Hours, Range 1–3 Hours.
Frequency of Response: Quarterly.
Estimated Number of Respondents:
VETS 201: 57.
Total Annualized Capital/startup
costs: $0.
Total Initial Annual Costs: $0.
Comments submitted in response to
this notice will be summarized and
included in the agency’s request for
OMB approval of the information
collection request. Comments will
become a matter of public record.
VerDate Sep<11>2014
19:24 Mar 02, 2015
Jkt 235001
Dated in Washington, DC, this 23rd day of
February 2015.
Ralph Charlip,
Deputy Assistant Secretary.
[FR Doc. 2015–04357 Filed 3–2–15; 8:45 am]
BILLING CODE 4510–79–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0020]
Information Collection: NRC Request
for Information Concerning Patient
Release Practices
Nuclear Regulatory
Commission.
AGENCY:
Proposed information
collection; request for comment.
ACTION:
The U.S. Nuclear Regulatory
Commission (NRC) invites public
comment on this proposed collection of
information. The information collection
is entitled, ‘‘NRC Request for
Information Concerning Patient Release
Practices.’’
SUMMARY:
Submit comments by May 4,
2015. Comments received after this date
will be considered if it is practical to do
so, but the Commission is able to ensure
consideration only for comments
received on or before this date.
DATES:
You may submit comments
by any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2015–0020. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• Mail comments to: Tremaine
Donnell, Office of Information Services,
Mail Stop: T–5 F53, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Tremaine Donnell, Office of Information
Services, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001; telephone: 301–415–6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
11471
I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2015–
0020 when contacting the NRC about
the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2015–0020. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing Docket ID
NRC–2015–0020 on this Web site.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. A copy
of the collection of information and
related instructions may be obtained
without charge by accessing ADAMS
Accession No. ML15015A612. The
supporting statement and Patient
Release Federal Register Notice
Soliciting Information is available in
ADAMS under Accession No.
ML15015A624.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting NRC’s Clearance
Officer, Tremaine Donnell, Office of
Information Services, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
6258; email: INFOCOLLECTS.Resource@
NRC.GOV.
B. Submitting Comments
Please include Docket ID NRC–2015–
0020 in the subject line of your
comment submission, in order to ensure
that the NRC is able to make your
comment submission available to the
public in this docket.
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC posts all comment
submissions at https://
E:\FR\FM\03MRN1.SGM
03MRN1
11472
Federal Register / Vol. 80, No. 41 / Tuesday, March 3, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
www.regulations.gov as well as entering
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the NRC, then you should
inform those persons not to include
identifying or contact information that
they do not want to be publicly
disclosed in their comment submission.
Your request should state that the NRC
does not routinely edit comment
submissions to remove such information
before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.
II. Background
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting
public comment on its intention to
request the OMB’s approval for the
information collection summarized
below.
1. The title of the information
collection: NRC Request for Information
Concerning Patient Release Practices.
2. OMB approval number: OMB
control number has not yet been
assigned to this proposed information
collection.
3. Type of submission: New.
4. The form number, if applicable: N/
A.
5. How often the collection is required
or requested: Once.
6. Who will be required or asked to
respond: Medical professional
organizations, physicians, patients,
patient advocacy groups, NRC and
Agreement State medical use licensees,
Agreement States, and other interested
individuals who use, receive, license or
have interest in the use of I–131 sodium
iodine (hereafter referred to as ‘‘I–131’’)
for the treatment of thyroid conditions.
7. The estimated number of annual
responses: A one-time collection
estimated to have 1,180 responses (620
medical community + 560 patients).
8. The estimated number of annual
respondents: 1,180 respondents (620
medical community + 560 patients).
9. The estimated number of hours
needed annually to comply with the
information collection requirement or
request: 457.5 hours (255 medical
community + 202.5 patients).
10. Abstract: The NRC is requesting a
one-time information collection that
will be solicited in a Federal Register
notice (FRN). The FRN will have
specific I–131 patient release questions
associated with: (1) Existing Web sites
that the responders believe provide
VerDate Sep<11>2014
19:24 Mar 02, 2015
Jkt 235001
access to clear and consistent patient
information about I–131 treatment
processes and procedures; (2)
information the responders believe
represent best practices used in making
informed decisions on releasing I–131
patients and stand alone or
supplemental voluntary patient/licensee
guidance acknowledgment forms, if
available; (3) an existing set of
guidelines that the responder developed
or received that provides instructions to
released patients; and (4) an existing
guidance brochure that the responder
believes would be acceptable for
nationwide distribution. The responses
will form the basis for patient release
guidance products developed in
response to the NRC’s April 28, 2014,
Staff Requirements—COMAMM–14–
0001/COMWDM–14–0001—
‘‘Background and Proposed Direction to
NRC Staff to Verify Assumptions Made
Concerning Patient Release Guidance.’’
The Commission, based on information
from patients and patient advocacy
groups, questioned the availability of
clear, consistent, patient friendly and
timely patient release information and
directed the staff to work with a wide
variety of stakeholders when developing
new guidance products. This
information collection effort was
developed to gain input from as many
stakeholders as possible. The NRC
solicitation in the Federal Register is to
obtain existing information from a
variety of stakeholders.
III. Specific Requests for Comments
The NRC is seeking comments that
address the following questions:
1. Is the proposed collection of
information necessary for the NRC to
properly perform its functions? Does the
information have practical utility?
2. Is the estimate of the burden of the
information collection accurate?
3. Is there a way to enhance the
quality, utility, and clarity of the
information to be collected?
4. How can the burden of the
information collection on respondents
be minimized, including the use of
automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 25th day
of February, 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information
Services.
[FR Doc. 2015–04318 Filed 3–2–15; 8:45 am]
BILLING CODE 7590–01–P
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
NUCLEAR REGULATORY
COMMISSION
[NRC–2015–0041]
Biweekly Notice; Applications and
Amendments to Facility Operating
Licenses and Combined Licenses
Involving No Significant Hazards
Considerations
Nuclear Regulatory
Commission.
ACTION: Biweekly notice.
AGENCY:
Pursuant to Section 189a. (2)
of the Atomic Energy Act of 1954, as
amended (the Act), the U.S. Nuclear
Regulatory Commission (NRC) is
publishing this regular biweekly notice.
The Act requires the Commission to
publish notice of any amendments
issued, or proposed to be issued and
grants the Commission the authority to
issue and make immediately effective
any amendment to an operating license
or combined license, as applicable,
upon a determination by the
Commission that such amendment
involves no significant hazards
consideration, notwithstanding the
pendency before the Commission of a
request for a hearing from any person.
This biweekly notice includes all
notices of amendments issued, or
proposed to be issued from February 5,
2015 to February 18, 2015. The last
biweekly notice was published on
February 17, 2015.
DATES: Comments must be filed by April
2, 2015. A request for a hearing must be
filed by May 4, 2015.
ADDRESSES: You may submit comments
by any of the following methods (unless
this document describes a different
method for submitting comments on a
specific subject):
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2015–0041. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–415–3463;
email: Carol.Gallagher@nrc.gov.
• Mail comments to: Cindy Bladey,
Office of Administration, Mail Stop:
OWFN–12–H08, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001.
For additional direction on obtaining
information and submitting comments,
see ‘‘Obtaining Information and
Submitting Comments’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Shirley Rohrer, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington DC
20555–0001; telephone: 301–415–5411,
email: Shirley.Rohrer@nrc.gov.
SUMMARY:
E:\FR\FM\03MRN1.SGM
03MRN1
Agencies
[Federal Register Volume 80, Number 41 (Tuesday, March 3, 2015)]
[Notices]
[Pages 11471-11472]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-04318]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2015-0020]
Information Collection: NRC Request for Information Concerning
Patient Release Practices
AGENCY: Nuclear Regulatory Commission.
ACTION: Proposed information collection; request for comment.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on this proposed collection of information. The information
collection is entitled, ``NRC Request for Information Concerning
Patient Release Practices.''
DATES: Submit comments by May 4, 2015. Comments received after this
date will be considered if it is practical to do so, but the Commission
is able to ensure consideration only for comments received on or before
this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2015-0020. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-415-
3463; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual listed in the FOR FURTHER INFORMATION CONTACT section of
this document.
Mail comments to: Tremaine Donnell, Office of Information
Services, Mail Stop: T-5 F53, U.S. Nuclear Regulatory Commission,
Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of
Information Services, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001; telephone: 301-415-6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2015-0020 when contacting the NRC
about the availability of information for this action. You may obtain
publicly-available information related to this action by any of the
following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2015-0020. A copy of
the collection of information and related instructions may be obtained
without charge by accessing Docket ID NRC-2015-0020 on this Web site.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly-available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. A
copy of the collection of information and related instructions may be
obtained without charge by accessing ADAMS Accession No. ML15015A612.
The supporting statement and Patient Release Federal Register Notice
Soliciting Information is available in ADAMS under Accession No.
ML15015A624.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
NRC's Clearance Officer: A copy of the collection of
information and related instructions may be obtained without charge by
contacting NRC's Clearance Officer, Tremaine Donnell, Office of
Information Services, U.S. Nuclear Regulatory Commission, Washington,
DC 20555-0001; telephone: 301-415-6258; email:
INFOCOLLECTS.Resource@NRC.GOV.
B. Submitting Comments
Please include Docket ID NRC-2015-0020 in the subject line of your
comment submission, in order to ensure that the NRC is able to make
your comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information that you do not want to be publicly disclosed in your
comment submission. The NRC posts all comment submissions at https://
[[Page 11472]]
www.regulations.gov as well as entering the comment submissions into
ADAMS. The NRC does not routinely edit comment submissions to remove
identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment submissions into ADAMS.
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
1. The title of the information collection: NRC Request for
Information Concerning Patient Release Practices.
2. OMB approval number: OMB control number has not yet been
assigned to this proposed information collection.
3. Type of submission: New.
4. The form number, if applicable: N/A.
5. How often the collection is required or requested: Once.
6. Who will be required or asked to respond: Medical professional
organizations, physicians, patients, patient advocacy groups, NRC and
Agreement State medical use licensees, Agreement States, and other
interested individuals who use, receive, license or have interest in
the use of I-131 sodium iodine (hereafter referred to as ``I-131'') for
the treatment of thyroid conditions.
7. The estimated number of annual responses: A one-time collection
estimated to have 1,180 responses (620 medical community + 560
patients).
8. The estimated number of annual respondents: 1,180 respondents
(620 medical community + 560 patients).
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 457.5 hours (255 medical
community + 202.5 patients).
10. Abstract: The NRC is requesting a one-time information
collection that will be solicited in a Federal Register notice (FRN).
The FRN will have specific I-131 patient release questions associated
with: (1) Existing Web sites that the responders believe provide access
to clear and consistent patient information about I-131 treatment
processes and procedures; (2) information the responders believe
represent best practices used in making informed decisions on releasing
I-131 patients and stand alone or supplemental voluntary patient/
licensee guidance acknowledgment forms, if available; (3) an existing
set of guidelines that the responder developed or received that
provides instructions to released patients; and (4) an existing
guidance brochure that the responder believes would be acceptable for
nationwide distribution. The responses will form the basis for patient
release guidance products developed in response to the NRC's April 28,
2014, Staff Requirements--COMAMM-14-0001/COMWDM-14-0001--``Background
and Proposed Direction to NRC Staff to Verify Assumptions Made
Concerning Patient Release Guidance.'' The Commission, based on
information from patients and patient advocacy groups, questioned the
availability of clear, consistent, patient friendly and timely patient
release information and directed the staff to work with a wide variety
of stakeholders when developing new guidance products. This information
collection effort was developed to gain input from as many stakeholders
as possible. The NRC solicitation in the Federal Register is to obtain
existing information from a variety of stakeholders.
III. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated at Rockville, Maryland, this 25th day of February, 2015.
For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-04318 Filed 3-2-15; 8:45 am]
BILLING CODE 7590-01-P